NASDAQ: PLSMPulsenmore Ltd Stock
$6.21+0.06 (+0.98%)
Updated Jan 27, 2026
PLSM Price
$6.21
Fair Value Price
N/A
Market Cap
$40.38M
52 Week Low
$5.81
52 Week High
$10.28
P/E
N/A
P/B
1.71x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.62
Operating Cash Flow
N/A
Beta
-14.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PLSM Overview
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PLSM's potential to beat the market
- PLSM doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
PLSM
RankedUnranked of 99
RankedUnranked of 99
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.08 | A | |
| $29.11 | A | |
| $7.92 | A |
Be the first to know about important PLSM news, forecast changes, insider trades & much more!
PLSM News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PLSM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PLSM is good value based on its book value relative to its share price (1.71x), compared to the US Medical Devices industry average (3.79x)
P/B vs Industry Valuation
PLSM's short-term assets ($35.63M) exceed its short-term liabilities ($4.47M)
Short-term Liabilities Financials
PLSM's short-term assets ($35.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more PLSM due diligence checks available for Premium users.
Valuation
PLSM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.71x
Industry
3.79x
PLSM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PLSM's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
Assets to liabilities
Assets
$35.6M
Liabilities
$13.6M
Debt to equity
0.62
PLSM's short-term assets ($35.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PLSM's short-term assets ($35.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PLSM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PLSM vs Medical Device Stocks
Pulsenmore Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.